Keensight Nova VII SCSp, a Luxembourg private equity fund, has raised $42.11M from nine investors since October 2025 and filed an amendment to its offering. The fund operates under Regulation D exemptions 3(c)(1) and 3(c)(7) with an indefinite offering size.
Note: Fund incorporated in 2025 and filed amendment in 2026; first sale dated 2025-10-31 indicates rapid deployment. Keensight Nova VII is Fund VII, suggesting established sponsor track record not detailed in this filing.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Sold rose to $42.1M (+$42.1M, +9 investors) in 365 days since the previous filing.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-10-30 | D | $0 | 0 | |
| 2026-10-30 | D/A | $42.1M | 9 | +$42.1M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Keensight Nova vehicles →
Website and main-office phone from Form ADV. Subscribe to unlock
Schedule D for this adviser has not been read yet; it is queued.
1 other filing on EDGAR under this adviser, with size, strategy and date. Subscribe to unlock
| N/A Keensight Nova VII GP S.a r.l. | Promoter |
| Arnaud Cohen | Executive Officer |
| Xavier Rouviere | Executive Officer |
| Valery Beuken | Executive Officer |
Signed by Xavier Rouviere, Class B Manager of the General Partner of the Issuer.
Placement agents / sales compensation: William Blair & Company, L.L.C.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
